D.E. Shaw & Co
SILK

D.E. Shaw & Co’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History

D.E. Shaw & Co’s Portfolio SILK Stock Details SILK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,154,781
Closed -$31.2M – 4990
2024
Q2 		$31.2M Sell
1,154,781
-444,710
-28% -$9.25M 0.03% 651
2024
Q1 		$29.3M Buy
1,599,491
+95,739
+6% +$1.52M 0.03% 702
2023
Q4 		$18.5M Buy
1,503,752
+1,362,939
+968% +$12.8M 0.02% 982
2023
Q3 		$2.11M Buy
140,813
+119,845
+572% +$2.49M ﹤0.01% 2520
2023
Q2 		$681K Sell
20,968
-84,714
-80% -$3.09M ﹤0.01% 3280
2023
Q1 		$4.14M Buy
105,682
+101,040
+2,177% +$4.94M ﹤0.01% 2099
2022
Q4 		$245K Buy
+4,642
New +$226K ﹤0.01% 4167

Other funds holding SILK

HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

D.E. Shaw & Co's SILK Position: Q3 2024 in Review

D.E. Shaw & Co sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q3 2024, closing a stake of 1,154,781 shares — an estimated $31.2M sold.

D.E. Shaw & Co first reported a position in SILK in Q4 2022 and held it in 7 quarters. The position peaked at $31.2M in Q2 2024. 1 fund tracked by Wall St. Rank holds SILK as of Q3 2024.

  • D.E. Shaw & Co reported no remaining Silk Road Medical, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • D.E. Shaw & Co sold 1,154,781 Silk Road Medical, Inc. Common Stock shares in Q3 2024, an estimated $31.2M.
  • D.E. Shaw & Co first reported a position in Silk Road Medical, Inc. Common Stock in Q4 2022 and held it in 7 quarters.
  • D.E. Shaw & Co's Silk Road Medical, Inc. Common Stock position peaked at $31.2M in Q2 2024.
  • 1 fund tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q3 2024.

Based on D.E. Shaw & Co's 13F filing for Q3 2024, filed 14 Nov 2024.